Total planned funding: $136,249,545
Allocations
Countries/Regions
India | $136,249,545 |
Organizational Types
Unknown | $48,324,126 |
NGO | $45,172,440 |
Own Agency | $21,169,671 |
University | $11,450,000 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $2,806,808 |
Private Contractor | $1,509,000 |
FBO | $1,300,000 |
Host Country Government Agency | $1,010,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $63,959,113 |
Prevention | $28,640,994 |
Management and Operations | $15,377,823 |
Care | $12,804,853 |
Treatment | $5,670,354 |
Testing | $5,368,616 |
Budget Codes
OHSS: Health Systems Strengthening | $37,471,150 |
HVSI: Strategic Information | $20,141,604 |
HVMS: Management and Operations | $15,377,823 |
HVOP: Sexual Prevention: Other Sexual Prevention | $15,238,976 |
HBHC: Care: Adult Care and Support | $7,884,433 |
HLAB: Laboratory Infrastructure | $6,346,359 |
HVCT: Testing: HIV Testing and Counseling | $5,368,616 |
HTXS: Treatment: Adult Treatment | $5,315,364 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,200,955 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,450,701 |
HKID: Care: Orphans and Vulnerable Children | $2,693,690 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,446,741 |
HMBL: Biomedical Prevention: Blood Safety | $2,303,621 |
HVTB: Care: TB/HIV | $2,024,001 |
PDTX: Treatment: Pediatric Treatment | $354,990 |
PDCS: Care: Pediatric Care and Support | $202,729 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$47,276,637
Countries/Regions
FHI 360:
$20,150,057
Countries/Regions
USG Aggregated Agencies:
$15,216,140
Countries/Regions
Voluntary Health Services:
$5,980,000
Countries/Regions